Geirmund Myklebust

Kristiansand, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Lifetime risk of malignancy in polymyalgia rheumatica: a population-based matched cohort study from southern Norway.

Lifetime risk of malignancy in polymyalgia rheumatica: a population-based matched cohort study from southern Norway.

Journal: Rheumatology (Oxford, England)
Published: February 02, 2026

Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study.

Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study.

Journal: Rheumatology (Oxford, England)
Published: October 07, 2025

Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study.

Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study.

Journal: Rheumatology (Oxford, England)
Published: October 07, 2025

Mortality in polymyalgia rheumatica: a 38-year prospective population-based cohort study from Southern Norway.

Mortality in polymyalgia rheumatica: a 38-year prospective population-based cohort study from Southern Norway.

Journal: Arthritis research & therapy
Published: April 25, 2025

Treatment and risk of relapse in GCA in Western Norway 2013-2020: a retrospective cohort study.

Treatment and risk of relapse in GCA in Western Norway 2013-2020: a retrospective cohort study.

Journal: Rheumatology advances in practice
Published: March 28, 2025

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review.

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review.

Journal: BMC rheumatology
Published: July 17, 2024

Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013-2020.

Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013-2020.

Journal: Frontiers in medicine
Published: September 18, 2023

Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria.

Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria.

Journal: Frontiers in medicine
Published: August 31, 2023

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis.

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis.

Journal: Frontiers in medicine
Published: October 28, 2022

Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist: reply.

Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist: reply.

Journal: Rheumatology (Oxford, England)
Published: February 11, 2022

Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist.

Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist.

Journal: Rheumatology (Oxford, England)
Published: February 18, 2021

Magnetic resonance imaging compared to ultrasonography in giant cell arteritis: a cross-sectional study.

Magnetic resonance imaging compared to ultrasonography in giant cell arteritis: a cross-sectional study.

Journal: Arthritis research & therapy
Published: July 01, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026